Baxdrostat for Treatment-Resistant Hypertension. Reply
N Engl J Med
.
2023 May 11;388(19):1821-1822.
doi: 10.1056/NEJMc2302673.
Authors
Mason W Freeman
1
,
Yuan-Di Halvorsen
1
,
Morris J Brown
2
Affiliations
1
CinCor Pharma, Boston, MA.
2
Queen Mary University of London, London, United Kingdom
[email protected]
.
PMID:
37163635
DOI:
10.1056/NEJMc2302673
No abstract available
Publication types
Letter
Kommentar
MeSH terms
Antihypertensive Agents / therapeutic use
Humans
Hypertension* / drug therapy
Substances
Antihypertensive Agents